申请人:Hoffmann-La Roche Inc.
公开号:US09334278B2
公开(公告)日:2016-05-10
The present invention relates to the use of novel pyrrolo[2,3-b]]pyrazines wherein all variable substituents are defined as described herein, which are SYK inhibitors and are useful for the treatment of auto-immune and inflammatory diseases.
本发明涉及使用新型吡咯并[2,3-b]吡嗪,其中所有可变取代基如本文所述,它们是SYK抑制剂,并且可用于治疗自身免疫和炎症性疾病。